This announcement is a separate document:
新疆百花村医药集团股份股份有限公司2021年度向特定对象发行A股股票方案论证分析报告（修订稿）
Xinjiang Baihuacun Pharmaceutical Group Co., Ltd. 2021 Solution Verification Analysis Report on the Issuance of A Shares to Specific Targets (Revised Draft)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.